News broke Saturday that Alexion Pharmaceuticals (ALXN) will be acquired by AstraZeneca (AZN) for $39 billion, representing a roughly 45% buyout premiumThis is the third big acquisition in the biotech sector in recent months and I hope bodes well for merger-and-acquisition activity in 2021. Bristol-Myers Squibb (BMY) agreed to buy Myokardia (MYOK)...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.